Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 44 points (0.3%) at 15,464 as of Tuesday, Aug. 13, 2013, 12:50 PM ET. The NYSE advances/declines ratio sits at 1,183 issues advancing vs. 1,800 declining with 78 unchanged. The Health Services industry currently sits down 0.6% versus the S&P 500, which is up 0.2%. A company within the industry that increased today was Smith & Nephew ( SNN), up 0.6%. TheStreet would like to highlight 4 stocks pushing the industry higher today: 4. CareFusion ( CFN) is one of the companies pushing the Health Services industry higher today. As of noon trading, CareFusion is up $0.62 (1.7%) to $37.72 on light volume. Thus far, 714,875 shares of CareFusion exchanged hands as compared to its average daily volume of 2.3 million shares. The stock has ranged in price between $37.02-$37.82 after having opened the day at $37.09 as compared to the previous trading day's close of $37.10. CareFusion Corporation provides various healthcare products and services in the United States and internationally. It operates in two segments, Medical Systems and Procedural Solutions. CareFusion has a market cap of $8.1 billion and is part of the health care sector. Shares are up 29.3% year to date as of the close of trading on Monday. Currently there are 6 analysts that rate CareFusion a buy, no analysts rate it a sell, and 6 rate it a hold. TheStreet Ratings rates CareFusion as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, increase in net income and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full CareFusion Ratings Report now. 3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.